Health Library

Scientific Publications

This section presents only real, published studies with DOI and direct PDF access.

Evidence set validated by the JET study

In the prospective study published on February 10, 2026 (n=60), the JET group showed statistically significant symptom and culture improvements.

Q1

International publication standard

22

Publication and patent outputs

25+

Scientific event contributions

Featured Q1 Publication

JET Product Publication: Published in a Q1 Journal under Gynecologist Guidance

DOI: 10.3390/jcm15041395. Negative culture rates improved from 40% to 80% in the JET group, while vaginal discharge findings dropped from 96.7% to 6.9%.

2026MDPI Journal of Clinical Medicine (Q1)DOI: 10.3390/jcm15041395

Publication and Evidence List

Review the PDF and Summary on Our Website

Below you can review the study summary, key findings, and embedded PDF preview without leaving the page.

2026International Article

Clinical Publication Developed Under Gynecologist Guidance During JET Product Development

In this prospective study of 60 women with acute vaginitis, the group using antimicrobial underwear in addition to standard treatment showed significant improvements in symptoms and culture outcomes.

DOI: 10.3390/jcm15041395

  • Negative culture rates increased from 40% to 80% in the antimicrobial group (p = 0.018).
  • Vaginal discharge improved from 96.7% to 6.9%; the control group remained at 72.5% to 27.5% (p < 0.001).
  • Pruritus, odor, and irritation outcomes were significantly better than control (p < 0.05).
  • The study documents the validation-driven R&D model we built in the JET product line with academic and physician partners.

Publication PDF Preview

If the preview does not load, open the publication in a new tab Open PDF.

Open to publication collaborations

For joint publications, project outputs, or technical report studies, contact our team directly.